SREBF1 and adenocarcinoma: We found a significant downregulation of SREBF1 in adenocarcinoma (ADC) and although statistically nonsignificant, also a downregulation in squamous cell carcinoma (SQCC) (Figure 8A, Supplementary Figure S4).